Old Web
English
Sign In
Acemap
>
Paper
>
P5717Risk of QTC interval prolongation among cancer patients treated with tyrosine kinase inhibitors
P5717Risk of QTC interval prolongation among cancer patients treated with tyrosine kinase inhibitors
2019
A Abu Rmilah
Grace Lin
J Hermann
Keywords:
Oncology
Prolongation
Tyrosine kinase
Diabetes mellitus
Cardiology
Internal medicine
QT interval
Medicine
Cancer
Pharmacology
Pazopanib
imatinib mesylate
Nilotinib
Dasatinib
Sunitinib
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]